Related Experiment Video
Updated: Jun 25, 2025

Author Spotlight: Detecting Low-Abundant Host Cell Proteins in Drug Products Using Enrichment Beads and Limited Digestion
Published on: January 19, 2024
Identification of Acyl-Protein Thioesterase-1 as a Polysorbate-Degrading Host Cell Protein in a Monoclonal Antibody
Ernest Šprager1, Jens Möller2, Yuhsien Lin2
1University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia; Novartis Technical Research & Development, Biologics Technical Development Mengeš, Novartis Pharmaceutical Manufacturing LLC, Slovenia.
Residual host cell proteins (HCPs) can degrade polysorbate (PS) in monoclonal antibody (mAb) formulations. Acyl-protein thioesterase-1 (APT-1) was identified as a key enzyme responsible for PS degradation, which can be inhibited to improve drug stability.
Area of Science:
- Biopharmaceutical Science
- Protein Chemistry
- Analytical Chemistry
Background:
- Polysorbate (PS) is crucial for monoclonal antibody (mAb) stability in formulations.
- Low-abundance residual host cell proteins (HCPs), especially hydrolytic enzymes, can degrade PS.
- This degradation impacts the shelf-life and efficacy of mAb therapeutics.
Purpose of the Study:
- To identify the specific HCP responsible for PS degradation in a problematic mAb formulation.
- To validate the identified HCP's role in PS breakdown.
- To explore methods for mitigating PS degradation.
Main Methods:
- Activity-based protein profiling (ABPP) combined with mass spectrometry.
- Recombinant protein expression and activity assays.
- Analysis of PS degradation products and HCP levels.
- Inhibition studies using specific APT1 inhibitors (ML348, ML211).
Main Results:
- Acyl-protein thioesterase-1 (APT-1) was identified as the primary PS-degrading HCP.
- A direct correlation was observed between APT1 levels and the rate of PS degradation.
- APT1 was found to co-purify with a specific mAb.
- PS degradation was successfully inhibited using APT1-specific inhibitors.
Conclusions:
- APT-1 is a critical HCP contributing to PS degradation in mAb formulations.
- ABPP offers a streamlined method for identifying critical HCPs involved in formulation instability.
- These findings support quality-by-design principles for developing stable biopharmaceutical products.
More Related Videos
10:50Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
Published on: May 1, 2019
11:09An HS-MRM Assay for the Quantification of Host-cell Proteins in Protein Biopharmaceuticals by Liquid Chromatography Ion Mobility QTOF Mass Spectrometry
Published on: April 17, 2018